Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of WE 941 OD vs Brotizolam in Healthy Males
NCT02218658Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2000
- Primary completion
- Aug 2000
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of brotizolam in Insomnia (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the plasma concentration-time curve from 0 to 24 hours and Maximum plasma concentration at 24 hours. Started Jul 2000; status: completed.
02
Drugs
brotizolam
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02218658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02218658.